Clinical Trials Search Results

Results 1-10 of 400 for your search
Show Search Criteria
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 834 locations
Dabrafenib and Trametinib in Treating Patients with Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 635 locations
Nivolumab after Combined Modality Therapy in Treating Patients with High Risk Stage II-IIIB Anal Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 585 locations
Pembrolizumab in Treating Patients with Stage III-IV High-Risk Melanoma Before and After Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 358 locations
Pembrolizumab in Treating Patients with Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 161 locations
1 2 3 ... 40 Next >